Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDX320 safety and antiviral activity study in genotype 1 chronic hepatitis C
ISRCTN44746369Phase 2Completed
- Sponsor
- Idenix Pharmaceuticals
- Start
- Feb 2010
- Modality
- Small Molecules
01
Overview
Phase 2, randomised trial of idx320 in hepatitis C virus infection, sponsored by Idenix Pharmaceuticals. Started Feb 2010; status: completed.
02
Drugs
idx320
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on ISRCTN44746369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN44746369.